Resolvyx Pharmaceuticals Garners $4,000,000 Series B Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b8f92d31-9737-47c9-a890-08e2fe2c5cae&Preview=1 -
Date
8/22/2008 -
Company Name
Resolvyx Pharmaceuticals -
Mailing Address
6A Preston Court Bedford, MA 01730 -
Company Description
Resolvyx is a biopharmaceutical company committed to the discovery and development of therapies based on the novel concept of inflammation resolution through activation of the body’s own off-switch mechanisms. -
Website
http://www.resolvyx.com/
-
Transaction Type
Venture Equity -
Transaction Amount
$4,000,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds from the financing will be used to accelerate the development of Resolvyx’s preclinical pipeline and to advance multiple resolvin drug candidates into clinical trials in 2008. -
M&A Terms
-
Venture Investor
QVT Fund LP -
Venture Investor
Atlas Venture -
Venture Investor
Flagship Ventures -
Venture Investor
Radius Ventures -
Venture Investor
CHL Medical Partners -
Venture Investor
Biogen Idec Inc.
